تصفح Public Health حسب المؤلف "Al-Ziftawi,Nour"
-
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
Al-Ziftawi, Nour Hisham; Alam, Mohammed Fasihul; Elazzazy, Shereen; Shafie, Asrul Akmal; Hamad, Anas; Mohamed Ibrahim, Mohamed Izham... more authors ... less authors ( MDPI , 2022 , Article)Palbociclib and ribociclib are indicated in the first-line treatment of hormonal-receptor-positive HER-2 negative (HR+/HER-2 negative) advanced breast cancer. Despite their clinical benefit, they can increase healthcare ...